4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide

C22H23F3N6O4S — CID 126507754

IUPAC4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide
SMILESO=S(=O)(N1CCN(C2COC2)CC1)N(Cc1ccc(-c2nnc(C(F)(F)F)o2)cn1)c1ccccc1
InChIInChI=1S/C22H23F3N6O4S/c23-22(24,25)21-28-27-20(35-21)16-6-7-17(26-12-16)13-31(18-4-2-1-3-5-18)36(32,33)30-10-8-29(9-11-30)19-14-34-15-19/h1-7,12,19H,8-11,13-15H2
InChIKeyRUCVFOIOCBMGFY-UHFFFAOYSA-N
MW524.53 g/mol
LogP2.42
Rot. Bonds7

About 4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide

4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide (PubChem CID 126507754) has the molecular formula C22H23F3N6O4S and a molecular weight of 524.53 g/mol. Its IUPAC name is 4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide.

Molecular Properties

Compound Name4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide
PubChem CID126507754
Molecular FormulaC22H23F3N6O4S
Molecular Weight524.53 g/mol
Exact Mass524.15
IUPAC Name4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide
SMILESO=S(=O)(N1CCN(C2COC2)CC1)N(Cc1ccc(-c2nnc(C(F)(F)F)o2)cn1)c1ccccc1
InChIInChI=1S/C22H23F3N6O4S/c23-22(24,25)21-28-27-20(35-21)16-6-7-17(26-12-16)13-31(18-4-2-1-3-5-18)36(32,33)30-10-8-29(9-11-30)19-14-34-15-19/h1-7,12,19H,8-11,13-15H2
InChIKeyRUCVFOIOCBMGFY-UHFFFAOYSA-N
XLogP2.42
TPSA104.90 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms36
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500524.53
LogP ≤ 52.42
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze 4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide?
The IUPAC name of 4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide (CID 126507754) is 4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide.
What is the SMILES notation for 4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide?
The canonical SMILES for 4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide is O=S(=O)(N1CCN(C2COC2)CC1)N(Cc1ccc(-c2nnc(C(F)(F)F)o2)cn1)c1ccccc1.
What is the InChIKey of 4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide?
The InChIKey is RUCVFOIOCBMGFY-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H23F3N6O4S/c23-22(24,25)21-28-27-20(35-21)16-6-7-17(26-12-16)13-31(18-4-2-1-3-5-18)36(32,33)30-10-8-29(9-11-30)19-14-34-15-19/h1-7,12,19H,8-11,13-15H2.
What are the key properties of 4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide?
4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide has a molecular weight of 524.53 g/mol, XLogP of 2.42, 7 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(oxetan-3-yl)-N-phenyl-N-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]piperazine-1-sulfonamide is sourced from PubChem (CID 126507754), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).